telmisartan has been researched along with Breast Cancer in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF | 1 |
| Aich, J; Devarajan, S; Kumar, U | 1 |
| To, KK; Tomlinson, B | 1 |
| Azoulay, L; Bartels, DB; Dell'Aniello, S; Suissa, S; Tascilar, K | 1 |
| Kociecka, B; Miltyk, W; Palka, J; Surazynski, A | 1 |
| Debanne, SM; Fang, JC; Rowland, DY; Simon, DI; Sipahi, I | 1 |
2 review(s) available for telmisartan and Breast Cancer
| Article | Year |
|---|---|
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells | 2022 |
Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Breast Neoplasms; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Neoplasms; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk; Telmisartan | 2010 |
4 other study(ies) available for telmisartan and Breast Cancer
| Article | Year |
|---|---|
Exploring the repurposing potential of telmisartan drug in breast cancer: an in-silico and in-vitro approach.
Topics: Antihypertensive Agents; Benzoates; Breast Neoplasms; Drug Repositioning; Female; Humans; Hypertension; Pharmaceutical Preparations; Telmisartan | 2023 |
Targeting the ABCG2-overexpressing multidrug resistant (MDR) cancer cells by PPARĪ³ agonists.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzimidazoles; Benzoates; Biological Transport; Breast Neoplasms; Chlorophyll; Drug Resistance, Neoplasm; Endocytosis; Female; HEK293 Cells; Humans; Kinetics; MCF-7 Cells; Neoplasm Proteins; Phosphatidylinositol 3-Kinase; Pioglitazone; PPAR gamma; Protein Transport; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; RNA Interference; Rosiglitazone; Signal Transduction; Telmisartan; Thiazolidinediones; Transfection; Up-Regulation | 2013 |
The Use of Telmisartan and the Incidence of Cancer.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Breast Neoplasms; Colorectal Neoplasms; Databases, Factual; Humans; Incidence; Lung Neoplasms; Male; Middle Aged; Proportional Hazards Models; Prostatic Neoplasms; Risk Assessment; Risk Factors; Telmisartan; Time Factors; United Kingdom | 2016 |
The effect of Telmisartan on collagen biosynthesis depends on the status of estrogen activation in breast cancer cells.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Breast Neoplasms; Cell Line, Tumor; Collagen; Dose-Response Relationship, Drug; Estrogens; Humans; PPAR gamma; Telmisartan | 2010 |